Taikang Asset logo

Taikang Asset

Asia, Beijing, China, Beijing

Description

Taikang Asset is an asset management firm.

Investor Profile

Taikang Asset has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (67%)
  • Series B (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Electronics
  • Manufacturing
  • Retail
  • Education
  • Language Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Taikang Asset frequently co-invest with?

BOCGI Zheshang Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Huaxing Growth Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Harvest Capital Management
Asia, Beijing, China, Beijing
Co-Investments: 1
Fortune Capital
North America, Florida, United States, Coral Gables
Co-Investments: 1
CPE
Asia, Beijing, China, Beijing
Co-Investments: 1
Country Garden Venture Capital
Asia, Jilin, China, Guangdong
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Taikang Asset?

Dizal Pharma

Shanghai, Shanghai, China

Dizal Pharma is a research-based biotechnology company.

BiotechnologyPharmaceutical
Post Ipo EquityApr 17, 2025
Amount Raised: $246,169,029
Dreame Technology

Suzhou, Jiangsu, China

Dreame Technology produces premium hairdryers and vacuums in the style of Dyson.

ElectronicsManufacturingRetail
Series COct 21, 2021
Amount Raised: $563,089,484
Orient Speech Therapy Center

Shenzhen, Guangdong, China

Chinese speech and language therapy operator .

EducationLanguage LearningSpeech Recognition
Series CJun 25, 2021
Amount Raised: $60,000,000

Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJun 6, 2018
Amount Raised: $35,000,000